![](https://privsource-prod.s3.amazonaws.com/4lpi1ggsfbjn2d14sjhuef0jn53r?response-content-disposition=inline%3B%20filename%3D%22bioventus.png%22%3B%20filename%2A%3DUTF-8%27%27bioventus.png&response-content-type=image%2Fpng&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA6NYHEBQEVFIPN3SJ%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T092026Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=f5aedca395a794cc782ce0808c8a7080a041666c102268a60090bfb9e645ecd0)
Bioventus Invests in CartiHeal
08.30.2021
CartiHeal, a privately-held medical device company headquartered in Israel and New Jersey, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.
Bioventus
Accelmed Partners
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →